D'Or Institute for Research and Education
44
3
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.3%
1 terminated/withdrawn out of 44 trials
90.0%
+3.5% vs industry average
14%
6 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (44)
TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC
Role: lead
Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment
Role: lead
Family and Patient Outcomes After Pediatric Intensive Care (FOREVER)
Role: lead
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst
Role: collaborator
Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote
Role: lead
Tolerance to Immunomodulatory Nutritional Therapy in Oncology Patients Undergoing Chemotherapy and Radiotherapy
Role: lead
Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project
Role: lead
Comprehensive Demographics and Clinical Profile of NSCLC Patients
Role: lead
Music for Surgical Intensive Care (MUSIC)
Role: lead
Encouraging Positive Parenting Habits
Role: lead
MOdifiable facTors to Improve VentilAtion ThErapy in ICU
Role: collaborator
Inspiratory Muscle Strength Training in Post-Covid Syndrome
Role: lead
Photobiomodulation Therapy to Reduce Pain and Inflammation in Patients With Gonarthrosis
Role: lead
Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure
Role: lead
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer
Role: lead
Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
Role: lead
Encouraging Positive Parenting Habits Through Digital Media
Role: lead
Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.
Role: lead
An Observer-blind, Cohort Randomized, Exploratory Phase 3 Study to Evaluate the Safety and Immunogenicity of Recombinant Covid-19 Vaccine, mRNA Covid-19 Vaccine and Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine as 4th Dose in Individuals Primed/ Boosted With Various Regimens
Role: lead
Role of Immunoscore® in Stage II-III Colorectal Cancer
Role: lead